MeiraGTx Holdings (MGTX) Research & Development (2017 - 2025)
MeiraGTx Holdings (MGTX) posted Research & Development of $476000.0 for Q4 2025, up 52.08% on a QoQ basis from $313000.0 in Q3 2025, and up 100.66% year-over-year from $237212.7 in Q4 2024.
MeiraGTx Holdings (MGTX) Research & Development (2017 - 2025) Analysis & Trends
MeiraGTx Holdings' Research & Development history runs 9 years deep, the most recent figure standing at $476000.0 for Q4 2025.
- Quarterly Research & Development rose 100.66% year-over-year to $476000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.8 million (down 79.64% YoY) and the FY2025 annual result came in at $4.8 million, down 79.64% from the prior year.
- Research & Development was $476000.0 for Q4 2025 at MeiraGTx Holdings, up from $313000.0 in the prior quarter.
- Across five years, Research & Development topped out at $34.9 million in Q2 2024 and bottomed at -$71.7 million in Q4 2024.
- A 5-year average of $14.2 million and a median of $20.8 million in 2021 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2021 — Research & Development surged 367.21% — and 2024, when it tumbled 312.97%.
- MeiraGTx Holdings' Research & Development stood at $13.2 million in 2021, then soared by 65.11% to $21.8 million in 2022, then soared by 54.7% to $33.7 million in 2023, then tumbled by 312.97% to -$71.7 million in 2024, then jumped by 100.66% to $476000.0 in 2025.
- Business Quant data shows MGTX's Research & Development at $476000.0 in Q4 2025, $313000.0 in Q3 2025, and $2.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 541.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -2.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.37 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 343.97 Mn |
| 10 | MeiraGTx Holdings | 973.21 Mn | 907.27 Mn | - | 476,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 476,000.00 |
| Sep 30, 2025 | 313,000.00 |
| Jun 30, 2025 | 2.68 Mn |
| Mar 31, 2025 | 1.38 Mn |
| Dec 31, 2024 | -71.71 Mn |
| Sep 30, 2024 | 26.24 Mn |
| Jun 30, 2024 | 34.93 Mn |
| Mar 31, 2024 | 34.32 Mn |
| Dec 31, 2023 | 33.67 Mn |
| Sep 30, 2023 | 27.86 Mn |
| Jun 30, 2023 | 19.94 Mn |
| Mar 31, 2023 | 22.32 Mn |
| Dec 31, 2022 | 21.77 Mn |
| Sep 30, 2022 | 16.86 Mn |
| Jun 30, 2022 | 24.00 Mn |
| Mar 31, 2022 | 23.10 Mn |
| Dec 31, 2021 | 13.18 Mn |
| Sep 30, 2021 | 21.61 Mn |
| Jun 30, 2021 | 15.19 Mn |
| Mar 31, 2021 | 16.71 Mn |